Literature DB >> 2165796

Decay of nitroprusside. II: In vivo.

C J Vesey1, B Sweeney, P V Cole.   

Abstract

Clinical experience suggests that nitroprusside (SNP) concentrations decay more rapidly in vivo than in vitro. Plasma concentrations of SNP were measured therefore in 20 patients at the end of an infusion, with mean arterial pressure (MAP) and cyanide (HCN) concentrations. Plasma SNP concentrations (20-243 micrograms litre-1; mean = 123.5 micrograms litre-1), were related to infusion rate (r = 0.66, P less than 0.001), and declined rapidly to a mean (SD) of 7.7 (4.5) micrograms litre-1 in 15 min. The decay of SNP correlated closely with the increase in arterial pressure (mean MAP vs log mean plasma SNP concentrations: r = -0.993, P less than 0.001), and was probably biphasic: mean (SD) T1/2 alpha = 0.89 (0.62) min, T1/2 beta = 14.3 (12) min. Mean plasma HCN and mean plasma SNP concentrations decreased together (r = 0.955, P less than 0.001), thus confirming that in vivo decomposition of the drug is the source of HCN.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165796     DOI: 10.1093/bja/64.6.704

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

1.  Low blood lymphocyte count at 30 days post transplant predicts worse acute GVHD and survival but not relapse in a large retrospective cohort.

Authors:  Z Gul; E Van Meter; M Abidi; I Ditah; M Abdul-Hussein; A Deol; L Ayash; L G Lum; E K Waller; V Ratanatharathorn; J Uberti; Z Al-Kadhimi
Journal:  Bone Marrow Transplant       Date:  2015-01-19       Impact factor: 5.483

2.  Influence of nitrovasodilators and endothelin-1 on rheology of human blood in vitro.

Authors:  R Walter; M Mark; R Gaudenz; L G Harris; W H Reinhart
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

3.  Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility.

Authors:  W Michael Dismuke; Jin Liang; Darryl R Overby; W Daniel Stamer
Journal:  Exp Eye Res       Date:  2013-12-27       Impact factor: 3.467

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.